All Stories

  1. Anatomical Determinants of the Left Atrial Electrograms: Wall Thickness and Myocardial Fat Infiltration
  2. Molecular Synergy and Inflammatory Activation in Pathogenesis and Therapy of Atrial Cardio-Metabolic Cardiomyopathy
  3. Revisiting the Link Between Substrate and Ventricular Tachycardia Rate: The Critical Role of Conduction Isthmus Structure and Function
  4. Atrial cardiomyopathy as a multidomain disease: longitudinal evidence for autonomic remodelling
  5. Thrombus Formation During Pulmonary Vein Ablation: When Routine Turns Risky
  6. Validation of an Imageless Electrocardiographic Imaging Technique for the Non-Invasive Mapping of Regular Atrial Tachyarrhythmias
  7. PAM-VT 2 Study: Long-Term Scar Evolution and Ablation Lesion Assessment by Late Gadolinium Enhancement Cardiac Magnetic Resonance After Ventricular Tachycardia Ablation
  8. NURSE-Led Care in Patients Undergoing Catheter Ablation for Atrial Fibrillation: The NURSECAT-AF Randomized Trial
  9. The HONEST Cohort Study
  10. Cardiac magnetic resonance to evaluate 3-dimensional ventricular substrate depth: Prognostic implications for ventricular tachycardia ablation approach
  11. Atrial Ectopic Beat Types and Atrial Fibrillation Risk
  12. A Complex Gaussian Process Framework for Coherent ECGI Mapping and Isthmus Identification in Reentrant VT
  13. Left Bundle Branch Versus Apical Pacing in Atrioventricular Block and Normal Cardiac Function Post-transcatheter Aortic Valve Implantation: PhysTAVI Trial
  14. DYNAMO Framework: Advancing non-invasive, rapid calibration in cardiac digital twin technology
  15. Hybrid one-stage atrial fibrillation ablation
  16. NURSE-led care in Patients Undergoing CATheter Ablation for Atrial Fibrillation: The NURSECAT-AF randomized trial
  17. Non-Invasive Assessment of the Ventricular Arrhythmogenic Substrate Using Electrocardiographic Imaging During Sinus Rhythm: the NIAVAS study
  18. Head-to-head comparison of pulsed-field ablation, high-power short-duration ablation, cryoballoon and conventional radiofrequency ablation by MRI-based ablation lesion assessment
  19. Non‐Endocardial Radiofrequency Ablation of Premature Ventricular Complexes (NERA‐PVC): Safety, Efficacy and Outcome
  20. Clinical Response to Resynchronization Therapy: Conduction System Pacing vs Biventricular Pacing. CONSYST-CRT trial
  21. Preoperative skin antiseptics for the prevention of cardiac implantable electronic device infections: chlorhexidine-alcohol versus povidone-iodine-alcohol
  22. Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
  23. PO-02-209 NON-INVASIVE ELECTROCARDIOGRAPHIC IMAGING TO STRATIFY RISK OF VENTRICULAR ARRHYTHMIA
  24. PO-02-210 SYSTEMATIC PERFORMANCE EVALUATION OF AN IMAGELESS ELECTROCARDIOGRAPHIC IMAGING APPROACH FOR MAPPING ATRIAL TACHYARRHYTHMIAS
  25. PO-FP-060 NON-INVASIVE IDENTIFICATION OF VENTRICULAR DECELERATION ZONES USING ELECTROCARDIOGRAPHIC IMAGING
  26. Postablation Arrhythmogenic Channels Predict Atrial Fibrillation Recurrence
  27. Assessing heart rate fragmentation to predict atrial fibrillation in the general population aged 65: the PROOF-AF study
  28. Predictors of failed left bundle branch pacing implant in heart failure with reduced ejection fraction: Importance of left ventricular diameter and QRS morphology
  29. Personalized voltage maps guided by cardiac magnetic resonance in the era of high-density mapping
  30. Regional conduction velocities determined by noninvasive mapping are associated with arrhythmia-free survival after atrial fibrillation ablation
  31. Implications of atrial cardiomyopathy in the incidence of cardioembolic events in patients with cryptogenic stroke
  32. Implicaciones de la miocardiopatía auricular en la incidencia de eventos cardioembólicos en pacientes con ictus criptogénico
  33. Non-endocardial radiofrequency ablation of premature ventricular complexes (NERA-PVC): safety, efficacy and outcome.
  34. Atrial cardiomyopathy revisited—evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American He...
  35. Substrate Mapping for Ventricular Tachycardia Ablation Through High-Density Whole-Chamber Double Extra Stimuli
  36. Failure of Left Bundle Branch Pacing Owing to Iterative Septal Perforation: A Word of Caution for Thin Septum and Highly Dilated Cardiomyopathy
  37. Longitudinal comparison of dyssynchrony correction and ‘strain’ improvement by conduction system pacing: LEVEL-AT trial secondary findings
  38. AB-482897-002 HEAD-TO-HEAD COMPARISON OF PULSED FIELD ABLATION, VERY HIGH POWER-SHORT DURATION, CRYOBALLOON AND CONVENTIONAL RADIOFREQUENCY ABLATION BY LGE-MRI-BASED ABLATION LESION ASSESSMENT
  39. PO-01-117 OMNIPOLAR AND VECTOR MAPPING IN PREMATURE VENTRICULAR CONTRACTIONS ABLATION: A COMPARISON WITH BIPOLAR MAPPING
  40. PO-02-073 VALIDATION OF BIDIRECTIONAL CAVOTRICUSPID ISTHMUS BLOCK USING ELECTROCARDIOGRAPHIC IMAGING
  41. PO-03-088 ASSESSING HEART RATE FRAGMENTATION TO PREDICT ATRIAL FIBRILLATION IN THE GENERAL POPULATION AGED 65
  42. PO-03-182 IMPLANT FAILURE PREDICTORS OF LEFT BUNDLE BRANCH PACING USED AS CARDIAC RESYNCHRONIZATION THERAPY: IMPORTANCE OF LEFT VENTRICULAR DIAMETER AND QRS MORPHOLOGY
  43. PO-04-103 PAM-VT2 STUDY: LONGITUDINAL ANALYSIS OF POST-ABLATION MAGNETIC RESONANCE PREDICTING VT RECURRENCES
  44. PO-06-076 IMPROVING FUNCTIONAL SUBSTRATE DELINEATION FOR ABLATION OF VENTRICULAR TACHYCARDIA USING HIGH-DENSITY ELECTROANATOMIC MAPPING AND DOUBLE VENTRICULAR EXTRA STIMULI PROTOCOL
  45. Same-day discharge after atrial fibrillation ablation under a nurse-coordinated standardized protocol
  46. Is Transesophageal Echocardiogram Mandatory for Patients Undergoing Ablation for Right Atrial Flutter with Uninterrupted Anticoagulants? A Prospective Single Registry.
  47. La desafiante pero vital tarea de abordar la fibrilación auricular en los ancianos para prevenir la insuficiencia cardiaca
  48. Addressing the challenging yet vital task of managing atrial fibrillation in older adults to prevent heart failure
  49. Understanding Heart Condition in Patients with Sinus Node Disease
  50. PO-03-242 THE BENEFIT OF A DOUBLE VENTRICULAR EXTRA STIMULI PROTOCOL TO IMPROVE FUNCTIONAL SUBSTRATE MAPPING DURING ABLATION OF VENTRICULAR TACHYCARDIA - THE S3-VT-FREE PROJECT
  51. Magnetic resonance detection of advanced atrial cardiomyopathy increases the risk for atypical atrial flutter occurrence following atrial fibrillation ablation
  52. Stepwise application of ECG and electrogram-based criteria to ensure electrical resynchronization with left bundle branch pacing
  53. PO-01-202 HEART RATE FRAGMENTATION AS A MARKER OF ALTERED ACTIVITY OF THE AUTONOMIC NERVOUS SYSTEM ACTIVITY : A NOVEL PREDICTOR OF ATRIAL FIBRILLATION OCCURRENCE IN THE GENERAL POPULATION
  54. PO-02-197 PREDICTORS OF ATRIAL FLUTTER RECURRENCE AFTER ATRIAL FIBRILLATION ABLATION: THE CRUCIAL ROLE OF STRUCTURAL AND MORPHOLOGICAL LEFT ATRIAL REMODELING
  55. PO-02-224 CONDUCTION VELOCITIES DETERMINED BY NON-INVASIVE ELECTROCARDIOGRAPHIC IMAGING PREDICT ARRHYTHMIA-FREE SURVIVAL AFTER PULMONARY VEIN ISOLATION
  56. PO-02-226 NON-INVASIVE ELECTROCARDIOGRAPHIC IMAGING FOR THE CHARACTERIZATION OF COMPLEX ATRIAL TACHYARRHYTHMIAS
  57. PO-03-012 STEPWISE APPLICATION OF ECG AND ELECTROGRAM BASED CRITERIA TO ENSURE ELECTRICAL RESYNCHRONIZATION WITH LEFT BUNDLE BRANCH PACING
  58. Unusual localization of huge fibroelastoma in a patient with previous reiterative chest radiotherapy
  59. Validation of a Novel Imageless Non-Invasive Electrocardiographic Imaging for the Characterization of Atrial Tachycardias
  60. Premature atrial contractions: A predictor of atrial fibrillation and a relevant marker of atrial cardiomyopathy
  61. Non-invasive assessment of pulmonary vein isolation durability using late gadolinium enhancement magnetic resonance imaging
  62. Évaluation de l’impact de la cardiopathie atriale dans les AVC ischémiques cryptogéniques
  63. Tachyarrhythmias in Congenital Heart Diseases: From Ion Channels to Catheter Ablation
  64. Prevention of Atrial Fibrillation After Atrial Flutter Ablation With Ramipril (from the PREFACE Study)
  65. Acute aortic valve dysfunction in a woman with livedo racemosa and memory impairment
  66. Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis
  67. Distance between the descending aorta and the left inferior pulmonary vein as a determinant of biophysical parameters during paroxysmal atrial fibrillation cryoablation
  68. Does Unidirectional Block Exist after a Radiofrequency Line Creation? Insights from Ultra-High-Density Mapping (The UNIBLOCK Study)
  69. Comparison of clockwise and counterclockwise right atrial flutter using high‐resolution mapping and automated velocity measurements
  70. Predictors of high‐degree conduction disturbances and pacemaker implantation after transcatheter aortic valve replacement: Prognostic role of the electrophysiological study
  71. Factors Influencing Stereotaxic Pulmonary Vein Isolation
  72. Is Transesophageal Echocardiogram Mandatory for Patients Undergoing Ablation for Right Atrial Flutter with Uninterrupted Anticoagulants? A Prospective Single Registry
  73. Reply
  74. Long-Term Follow-Up of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator
  75. Impact of β‐blocker therapy on right ventricular function in heart failure patients with reduced ejection fraction. A prospective evaluation
  76. Comparison of Atrial Remodeling Caused by Sustained Atrial Flutter Versus Atrial Fibrillation
  77. Cardiovascular disease events within 5 years after a diagnosis of breast cancer
  78. Management of Left Ventricular Thrombi with Direct Oral Anticoagulants: Retrospective Comparative Study with Vitamin K Antagonists
  79. Role of atrial arrhythmia and ventricular response in atrial fibrillation induced atrial remodeling
  80. Impact of sacubitril/valsartan on echo parameters in heart failure patients with reduced ejection fraction a prospective evaluation
  81. What's next after the clot? Residual pulmonary vascular obstruction after pulmonary embolism: From imaging finding to clinical consequences
  82. An N-/L-Type Calcium Channel Blocker, Cilnidipine, Suppresses Autonomic, Electrical and Structural Remodeling Associated with Atrial Fibrillation
  83. Postoperative atrial fibrillation: mechanisms, manifestations and management
  84. Translational Challenges in Atrial Fibrillation
  85. Comparison of prevalence and management of left atrial appendage thrombi under old and new anticoagulants prior to left atrial catheter ablation
  86. Atrial fibrillation in cancer patients: Hindsight, insight and foresight
  87. Atrial Cardiomyopathy
  88. Reply to the letter to Editor “Is hybrid subcutaneous implantable cardioverter-defibrillator and leadless pacemaker the future of device therapy?”
  89. Un nodule pas si flou
  90. Substantial superiority of Niobe ES over Niobe II system in remote-controlled magnetic pulmonary vein isolation
  91. Transcatheter leadless cardiac pacing
  92. Robotic magnetic navigation for ablation of human arrhythmias
  93. Is the new Micra-leadless pacemaker entirely safe?
  94. Sutureless aortic bioprosthesis valve implantation and bicuspid valve anatomy: an unsolved dilemma?
  95. Sutureless Valve Implantation in Sievers Type 0 Bicuspid Annuli: A Word of Caution
  96. Correlation of Physical Activities and Breast Cancer Characteristics: A Prospective Analysis with Special Focus on Triple Negative Breast Cancer
  97. Évaluation du dépistage des cancers de la femme et du dépistage après 75 ans dans le département de la Loire
  98. Vers une approche intégrée des toxicités cardiovasculaires liées aux traitements du cancer du sein
  99. Réentraînement à l’activité physique dans la prise en charge globale du cancer du sein : étude pilote monocentrique
  100. Mise en place d'une étude pilote de sensibilisation au réentraînement à l'activité physique dans deux populations sélectionnées atteintes d'un cancer du sein
  101. Recommendations for a lifestyle which could prevent breast cancer and its relapse: Physical activity and dietetic aspects
  102. Quantification de l’activité physique journalière des patientes traitées pour un cancer du sein et comparaison avec deux populations témoins
  103. Déterminants du remodelage atrial et de son effet pro-arythmique dans la fibrillation atriale